Short answer
Covista Inc. (CVSA) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $487M (up 4.5% year over year) with net income of $42M.
Q1 2026 key financials · XBRL
- Revenue
- $487M
- +4.5% YoY · −3.2% QoQ
- Net income
- $42M
- −31.6% YoY · −45.5% QoQ
- Operating margin
- 18.8%
- EPS (diluted)
- $1.22
- −23.3% YoY · −41.9% QoQ
Source: XBRL data from the Covista Inc. (CVSA) Q1 2026 10-Q on SEC EDGAR. USD.
Covista Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $487.0M, up 4.5% YoY from $466.1M
- GAAP operating margin 18.8% vs 19.4% YoY; adjusted margin 21.0% vs 22.6%
- Medical and Veterinary strongest segment, revenue $103.5M, up 8.9%; Chamberlain weakest, up 2.3% to $197.0M
- Term Loan B refinancing $510.0M; $508.3M prior debt repaid
- Share repurchases 637,538 shares at average $103.04; cost pressures from labor, marketing, and growth investments
Risk Factors
- Risk Factors section not provided in submitted filing text
- Share repurchases: 637,538 shares bought at average $103.04
- Liquidity allocation: $661,811,630 remaining under repurchase plans
- Debt financing: Credit Agreement amended March 2, 2026
- Insider trading compliance: former CMO’s 10b5-1 Plan covers 8,753 shares
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Covista Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.